NCT02063308View on ClinicalTrials.gov

Oxaloacetate Pharmacokinetics and Safety

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Alzheimer's Disease
Interventions
DIETARY_SUPPLEMENT

Oxaloacetate (OAA)

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

Russell Swerdlow, MD

OTHER

NCT02063308 - Oxaloacetate Pharmacokinetics and Safety | Biotech Hunter | Biotech Hunter